The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of the CDK4/6 inhibitor palbociclib (P) as single agent or in combination with the same endocrine therapy (ET) received prior to disease progression, in patients (pts) with hormone receptor positive (HR+) HER2 negative (HER2−) metastatic breast cancer (mBC) (TREnd trial).
 
Luca Malorni
Honoraria - AstraZeneca; Pfizer
Consulting or Advisory Role - AstraZeneca; Pfizer
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Janssen; Puma Biotechnology; Roche
 
Giuseppe Curigliano
Consulting or Advisory Role - Pfizer; Roche/Genentech
Speakers' Bureau - Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Alessandro Marco Minisini
Consulting or Advisory Role - AstraZeneca; AstraZeneca (I); Novartis; Novartis (I); Pierre Fabre; Pierre Fabre (I); Roche; Roche (I)
 
Saverio Cinieri
No Relationships to Disclose
 
Carlo Tondini
No Relationships to Disclose
 
Grazia Arpino
Honoraria - Roche; Takeda
Consulting or Advisory Role - Amgen; Eisai; GlaxoSmithKline; Roche; Takeda
Research Funding - Eisai
Expert Testimony - Celgene
Travel, Accommodations, Expenses - Roche
 
Lorenzo Pavesi
No Relationships to Disclose
 
Angelo Martignetti
No Relationships to Disclose
 
Carmen Criscitiello
No Relationships to Disclose
 
Fabio Puglisi
Consulting or Advisory Role - AstraZeneca; Celgene; Novartis; Pfizer; Pierre Fabre; Roche; Takeda
 
Marta Pestrin
No Relationships to Disclose
 
Giuseppina Sanna
No Relationships to Disclose
 
Erica Moretti
No Relationships to Disclose
 
Emanuela Risi
No Relationships to Disclose
 
Chiara Biagioni
No Relationships to Disclose
 
Luca Boni
No Relationships to Disclose
 
Daniela Baldari
No Relationships to Disclose
 
Marc E. Buyse
Employment - IDDI
Stock and Other Ownership Interests - IDDI
 
Laura Biganzoli
No Relationships to Disclose
 
Angelo Di Leo
Honoraria - AstraZeneca; Bayer; Celgene; Eisai; Genomic Health; Lilly; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Celgene; Lilly; Novartis; Pfizer; Pierre Fabre; Puma Biotechnology; Roche
Research Funding - AstraZeneca; Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Celgene; Eisai; Lilly; Novartis; Pfizer; Pierre Fabre; Puma Biotechnology; Roche